(Q36731145)

15 August 2017

1 reference

title

Monitoring thrombolytic therapy (English)

1 reference

Cardiology and cardiovascular medicine

15 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

10 November 2022

author name string

E. G. Bovill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728788

10 November 2022

R. Becker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728788

10 November 2022

R. P. Tracy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728788

10 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1728788

10 November 2022

publication date

1 January 1992

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:003306209290022R?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

https://api.elsevier.com/content/article/PII:003306209290022R?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Progress in Cardiovascular Diseases

10 November 2022

published in

1 reference

15 August 2017

34

1 reference

15 August 2017

4

1 reference

15 August 2017

279-294

1 reference

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

15 August 2017

2

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial

10 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction

10 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction

10 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

10 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

The maintenance of a sustained thrombolytic state in man. II. Clinical observations on patients with myocardial infarction and other thromboembolic disorders

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

10 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Fibrin: structure and interactions

10 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Characterization of the inhibition of fibrin assembly by fibrinogen fragment D

10 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

High-dose, brief-duration intravenous infusion of streptokinase in acute myocardial infarction: description of effects in the circulation

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction

10 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Intracoronary thrombolysis with an acylated streptokinase-plasminogen activator (BRL 26921) in patients with acute myocardial infarction

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Relative importance of thrombin compared with plasmin-mediated platelet activation in response to plasminogen activation with streptokinase

10 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Tissue plasminogen activator promotes platelet disaggregation in plasma

10 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Plasmin inhibition of platelet function and of arachidonic acid metabolism

10 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial

10 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group

10 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical t

10 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment

10 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Platelets and thrombolysis

10 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator

10 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Prevention of thrombosis and rethrombosis. New approaches

10 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Platelets and thrombolytic therapy

10 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Acute myocardial infarction: Intracoronary application of nitroglycerin and streptokinase

10 November 2022

39

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Non surgical coronary artery recanalization in acute transmural myocardial infarction

10 November 2022

40

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Prevention of myocardial infarction by very early treatment with intracoronary streptokinase. Some clinical observations

10 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Variability, reproducibility, and applications of precordial ST-segment mapping following acute myocardial infarction

10 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Precordial ST-segment mapping 3. Stability of maps in the early phase of acute myocardial infarction

10 November 2022

43

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Myocardial infarction and thrombolysis. Electrocardiographic short term and long term results using precordial mapping

10 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Noninvasive detection of coronary artery patency using continuous ST-segment monitoring

10 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis

10 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog

10 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Time course of changes in ventricular fibrillation threshold in myocardial infarction: characteristics of acute and slow occlusion with respect to the collateral vessels of the heart

10 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Reperfusion ventricular tachyarrhythmias: correlation with antecedent coronary artery occlusion tachyarrhythmias and duration of myocardial ischemia

10 November 2022

49

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Early afterdepolarizations induced in vivo by reperfusion of ischemic myocardium. A possible mechanism for reperfusion arrhythmias

10 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Instantaneous and delayed ventricular arrhythmias after reperfusion of acutely ischemic myocardium: evidence for multiple mechanisms

10 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Arrhythmias in the assessment of coronary artery reperfusion following thrombolytic therapy

10 November 2022

52

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction

10 November 2022

53

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography

10 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB

10 November 2022

55

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Noninvasive detection of reperfusion in acute myocardial infarction based on plasma activity of creatine kinase MB subforms

10 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

A study on the dimeric structure of creatine kinase (EC 2.7.3.2).

10 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Isoelectric focusing and hybridisation experiments on creatine kinase (EC 2.7.3.2)

10 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Creatine kinase MM isoenzyme subforms in myocardium, cardiac lymph and blood after coronary artery occlusion in dogs

10 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Early detection of myocardial reperfusion by assay of plasma MM-creatine kinase isoforms in dogs

10 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Diagnostic changes in plasma creatine kinase isoforms early after the onset of acute myocardial infarction

10 November 2022

61

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Optimal criteria for rapid detection of myocardial reperfusion by creatine kinase MM isoforms in the presence of residual high grade coronary stenosis

10 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction

10 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Fibrinopeptide A: a marker of acute coronary thrombosis

10 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysis

10 November 2022

65

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy

10 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Relation of plasma D-dimer concentrations to coronary artery reperfusion before and after thrombolytic treatment in patients with acute myocardial infarction

10 November 2022

67

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

10 November 2022

70

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency. European Co-operative S

10 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Importance of adequate heparin dosage in arterial angioplasty in a porcine model

10 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

10 November 2022

73

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators

10 November 2022

74

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time

10 November 2022

76

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction

10 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction

10 November 2022

78

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Epidemiological characteristics of platelet aggregability.

10 November 2022

80

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study

10 November 2022

81

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Platelet hyperreactivity and prognosis in survivors of myocardial infarction

10 November 2022

82

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Platelet hyperreactivity and prognosis in survivors of myocardial infarction

10 November 2022

83

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Myocardial salvage by intracoronary thrombolysis in evolving acute myocardial infarction: Evaluation using intracoronary injection of thallium-201

10 November 2022

85

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Myocardial Salvage after Intracoronary Thrombolysis with Streptokinase in Acute Myocardial Infarction

10 November 2022

86

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Scintigraphic evidence of the "no reflow" phenomenon in human beings after coronary thrombolysis

10 November 2022

87

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Use of dual intracoronary scintigraphy with thallium-201 and technetium-99m pyrophosphate to predict improvement in left ventricular wall motion immediately after intracoronary thrombolysis in acute myocardial infarction

10 November 2022

88

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Coronary artery reperfusion in acute myocardial infarction: beneficial effects of intracoronary streptokinase on left ventricular salvage and performance

10 November 2022

89

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

The effect of intracoronary thrombolysis with streptokinase on myocardial thallium distribution and left ventricular function assessed by blood-pool scintigraphy

10 November 2022

90

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Coronary artery reperfusion in acute myocardial infarction: assessment by pre- and postintervention thallium-201 myocardial perfusion imaging

10 November 2022

91

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Intracoronary thrombolysis in acute myocardial infarction: correlations among serum enzyme, scintigraphic and hemodynamic findings

10 November 2022

92

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile

10 November 2022

93

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy

10 November 2022

94

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium

10 November 2022

95

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Improved in vivo magnetic resonance imaging of acute myocardial infarction after intravenous paramagnetic contrast agent administration

10 November 2022

96

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion

10 November 2022

97

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis

10 November 2022

98

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Bleeding complications in thrombolytic therapy

10 November 2022

99

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management

10 November 2022

100

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Thrombolytic therapy: current status (2).

10 November 2022

101

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Thrombolytic therapy: current status (1).

10 November 2022

102

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Thrombolytic therapy with streptokinase using a standard dosage

10 November 2022

104

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Improved survival after early thrombolysis in acute myocardial infarction. A randomised trial by the Interuniversity Cardiology Institute in The Netherlands

10 November 2022

106

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction

10 November 2022

107

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial

10 November 2022

108

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage

10 November 2022

109

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study

10 November 2022

110

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Reduced frequency of ventricular fibrillation after early thrombolysis in myocardial infarction

10 November 2022

111

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

10 November 2022

112

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

10 November 2022

113

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty

10 November 2022

114

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group

10 November 2022

115

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Coronary angioplasty for acute mitral regurgitation due to myocardial infarction. A nonsurgical treatment preserving mitral valve integrity

10 November 2022

118

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock

10 November 2022

120

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction

10 November 2022

121

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Treatment of recurrent ischemia after thrombolysis and successful reperfusion for acute myocardial infarction: effect on in-hospital mortality and left ventricular function

10 November 2022

122

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia

10 November 2022

123

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator

10 November 2022

124

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

Streptokinase in acute myocardial infarction. European Cooperative Study Group for Streptokinase Treatment in Acute Myocardial Infarction

10 November 2022

126

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90022-R

10 November 2022

Identifiers

1 reference

15 August 2017

1 reference